Transforming growth factor-β1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells

Endocrinology

Volumn 139, Issue 8, 1998, Pages 3569-3577

  Gerdes, Michael J ^a   Dang, Truong D ^a   Larsen, Melinda ^a   Rowley, David R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HORMONAL REGULATION; HORMONE RESPONSE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; STROMA CELL; TRANSCRIPTION REGULATION;

EID: 0031760760     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.8.6138     Document Type: Article

References (61)

1. Cunha GR, Chung LWK 1981 Stromal-epithelial interactions. I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice. J. Steroid Biochem 14:1317-1321
2. Chung LWK, Cunha GR 1983 Stromal-epithelial interactions, II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme. Prostate 4:503-511
3. Cunha GR, Hayward SW, Dahiya R, Foster BA 1996 Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat 155:63-72
4. Bonkhoff H, Remberger K 1996 Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Prostate 28:98-106
5. Cooke PS, Young P, Cunha GR 1991 Androgen receptor expression in developing male reproductive organs. Endocrinology 128:2867-2873
6. Prins GS, Birch L 1995 The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136:1303-1314
7. Prins GS, Cooke PS, Birch L, Donjacour AA, Yalcinkaya TM, Siiteri PK, Cunha GR 1992 Androgen receptor expression and 5α-reductase activity along the proximal-distal axis of the rat prostatic duct. Endocrinology 130:3066-3073
8. Cunha GR 1994 Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer [Suppl] 74:1030-1044
9. Prins GS, Birch L, Greene GL 1991 Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129:3187-3199
10. Reinikainen P, Palvimo JJ, Janne OA 1996 Effects of mitogens on androgen receptor-mediated transactivation. Endocrinology 137:4351-4357
11. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H 1994 Androgn receptor activation in prostatic tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor, and epidermal growth factor. Cancer Res 54:5474-5478
12. Ikonen T, Palvimo JJ, Kallio PJ, Reinikainen P, Janne OA 1994 Stimulation of androgen-regulated transactivation by modulators of protein phosphorylation. Endocrinology 135:1359-1366
13. Cunha GR, Aland ET, Turner T, Donjacour AA, Boutin EL, Foster BA 1992 Normal and abnormal development of the male urogenital tract: role of androgens, mesenchymal-epithelial interaction and growth factors. J Androl 13:465-475
14. Kim IY, Ahn HJ, Zelner DJ, Park L, Sensibar JA, Lee C 1996 Expression and localization of transforming growth factor-β receptors type I and type II in the rat ventral prostate during regression. Mol Endocrinol 10:107-115
15. Kyprianou N, Isaacs JT 1989 Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3:1515-1522
16. Kyprianou N, Isaacs JT 1988 Identification of a cellular receptor for transforming growth factor-β in rat ventral prostate and its negative regulation by androgen. Endocrinology 123:2124-2131
17. Thompson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC, Scardino PT, Park SH 1992 Transforming growth factor β1 as a biomarker for prostate cancer. J Cell Biochem 16H:54-61
18. Steiner MS, Zhou Z-Z, Tonb DC, Barrack ER1994 Expression of transforming growth factor-β1 in prostate cancer. Endocrinology 135:2240-2247
19. Gerdes MJ, Larsen M, McBride L, Dang TD, Lu B, Rowley DR 1998 Localization of transforming growth factor β1 and type II receptors in developing normal human prostate and carcinoma tissues. J Histochem Cytochem 46:379-388
20. Gerdes MJ, Dang TD, Lu B, Larsen M, McBride L, Rowley DR 1996 Androgen-regulated proliferation and gene transcription in a prostate smooth muscle cell line (PS-1). Endocrinology 137:864-872
21. Rowley DR, Dang TD, Larsen M, Gerdes MJ, McBride L, Lu B 1995 Purification of a novel protein (ps20) from urogenital sinus mesenchymal cells with growth inhibitory properties in vitro. J Biol Chem 270:22058-22065
22. Larsen M, Ressler SJ, Lu B, Gerdes MJ, McBride L, Dang TD, Rowley DR 1998 Molecular cloning and expression of ps20 growth inhibitor: a novel WAP-type "four disulfide core" domain protein expressed in smooth muscle. J Biol Chem 273:4574-4584
23. Rowley DR, Tindall DJ 1987 Responses of NBT-II bladder carcinoma cells to conditioned medium from normal fetal urogenital sinus. Cancer Res 47:2955-2960
24. Rowley DR 1992 Characterization of a fetal urogenital sinus mesenchymal cell line U4F: secretion of a negative growth regulatory activity. In Vitro Cell Dev Biol 28:29-38
25. Gelman J, Garban H, Shen R, Ng C, Cai L, Rajfer J, Gonzalez-Cadavid N 1998 Transforming growth factor β1 (TGF-β1) in penile and prostate growth in the rat during sexual maturation. J Androl 19:50-57
26. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Lang S, Kato M, Oefelein MG, Miyazono K, Nemeth JA, Kozlowski JM, Lee C 1996 Loss of expression of transforming growth factor βtype I and type II receptors correlates with tumor grade in human prostate cancer tissues. Clin Cancer Res 2:1255-1261
27. Gou Y, Jacobs SC, Kyprianou N 1997 Down-regulation of protein and mRNA expression for transforming growth factor-β (TGF-β1) type I and type II receptors in human prostate cancer. Int J Cancer 71:573-579
28. Williams RH, Stapleton AMF, Yang G, Truong LD, Rogers E, Timme TL, Wheeler TM, Scardino PT, Thompson TC 1996 Reduced levels of transforming growth factor β receptor type II in human prostate cancer: an immunohistochemical study. Clin Cancer Res 2:635-640
29. Kemppainen JA, Lane MV, Sar M, Wilson EM 1992 Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. J Biol Chem 267:968-974
30. Zhou Z, Kemppainen JA, Wilson EM 1995 Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol 9:605-615
31. O'Malley B 1990 The steroid receptor superfamily: more excitement predicted for the future. Mol Endocrinol 4:363-369
32. Zhou Z, Kemppainen JA, Wilson EM 1995 Identification of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol 9:605-615
33. Smith DF, Toft DO 1993 Steroid receptors and their associated proteins. Mol Endocrinol 7:4-11
34. Madan AP, DeFranco DB 1993 Bidirectional transport of glucocorticoid receptors across the nuclear envelope. Proc Natl Acad Sci USA 90:3588-3592
35. Chandran UR, DeFranco DB 1992 Internuclear migration of chicken progesterone receptor, but not simian virus-40 large tumor antigen, in transient heterokaryons. Mol Endocrinol 6:837-844
36. Akner G, Wilkstrom A-C, Gustafsson J-A 1994 Subcellular distribution of the glucocorticoid receptor and evidence for its association with microtubules. J Steroid Biochem Mol Biol 52:1-55
37. Czar MJ, Owens-Grillo JK, Yem AW, Leach KL, Deibel MR, Welsh MJ, Pratt WB 1994 The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol Endocrinol 8:1731-1741
38. Czar MJ, Lyons RH, Welsch MJ, Renoir J, Pratt WB 1995 Evidence that the fk506-binding immunophilin heat shock protein 56 is required for trafficking of the glucocorticoid receptor from the cytoplasm to the nucleus. Mol Endocrinol 9:1549-1560
39. Tai P-K, Maeda Y, Nakao K, Wakim NG, Duhring JL, Faber LE 1986 A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry 25:5269-5275
40. King WJ, Greene GL 1984 Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307:745-747
41. Guiochon-Mantel A, Loosfelt H, Lescop P, Sar S, Atger M, Perrot-Applanat M, Milgrom E 1989 Mechanisms of nuclear localization of the progesterone receptor: evidence for interaction between monomers. Cell 57:1147-1154
42. Wikstrom AC, Bakke O, Okret S, Bronnegard M, Gustafsson JA 1987 Intracellular localization of the glucocorticoid receptor: evidence for cytoplasmic and nuclear localization. Endocrinology 120:1232-1242
43. Husmann DA, Wilson CM, McPhaul M, Tilley WD, Wilson JD 1990 Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate Endocrinology 126:2359-2368
44. Prins GS, Birch L 1993 Immunocytochemical analysis of androgen receptor along the ducts of the separate rat prostate lobes after androgen withdrawal and replacement. Endocrinology 132:169-178
45. Sar M, Lubahn DB, French FS, Wilson EM 1990 Immunohistochemical localization of the androgen receptor in rat and human tissues. Endocrinology 127:3180-3186
46. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Oushi Y, Muramatsu M, Orimo H 1993 Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun 195:730-736
47. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye J-C 1995 Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology 136:1523-1529
48. Roberson KM, Edwards DW, Chang GC, Robertson CN 1995 Isolation and characterization of a novel human prostatic stromal culture: DuK50. In Vitro Cell Dev Biol Anim 31:840-845
49. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EM, Murphy GP 1983 LNCaP model of human prostatic carcinoma Cancer Res 43:1809-1817
50. Berns EMJJ, de Boer W, Mulder E 1986 Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9:247-259
51. Kim IY, Ahn HJ, Zelner DJ, Shaw JW, Sensibar JA, Kim JH, Kato M, Lee C 1996 Generic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res 56:44-48
52. Ritchie CK, Andrews LR, Thomas KG, Tindall DJ, Fitzpatrick LA 1997 The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastaric disease. Endocrinology 138:1145-1150
53. Wilding G, Zugmeier G, Knabbe C, Flanders K, Gelmann E 1989 Differential effects of transforming growth factor βon human prostate cancer cells in vitro. Mol Cell Endocrinol 62:79-87
54. Goldstein D, O'Leary M, Mitchen J, Borden EC, Wilding G 1991 Effects of interferon beta ser and transforming growth factor beta on prostatic cell lines J Urol 146:1173-1177
55. Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C 1996 Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone. Exp Cell Res 222:103-110
56. Miniati DN, Chang Y, Shu WP, Peehl DM, Liu BC 1996 Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells. Cancer Lett 104:137-144
57. Henttu P, Vihko P 1993 Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res 53:1051-1058
58. Schuurmans AL, Bolt J, Veldscholte J, Mulder E 1991 Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40:193-197
59. Syms AJ, Norris JS, Smith RG 1983 Proliferation of a highly androgensensitive ductus deferens cell line (DDT1 MF-2) is regulated by glucocorticoids and modulated by growth on collagen. In Vitro 12:929-936
60. Hall JA, Harris MA, Intres R, Harris SE 1997 Acidic fibroblast growth factor gene 5′ non-coding exon and flanking region from hamster DDT1 cells: identification of the promoter region and transcriptional regulation by testosterone and aFGF protein. J Cell Biochem 51:116-127
61. Hall JA, Harris MA, Malark M, Mansson PE, Zhou H, Harris SE 1990 Characterization of the hamster DDT-1 cell aFGF/HGBF-1 gene and cDNA and its modulation by steroids. J Cell Biochem 43:17-26